Scientists trace radioactive drug through healthy volunteers
Knowledge-focused
Not yet recruiting
This is a very early, first-in-human study to understand how a potential new drug for non-Hodgkin lymphoma is processed by the body. Six healthy adult male volunteers will take a single, small oral dose containing a tiny, safe amount of radioactive tracer. Researchers will closel…
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC